Development progress and application of monoclonal antibody drugs against respiratory virus
10.13200/j.cnki.cjb.003805
- VernacularTitle:抗呼吸道病毒单克隆抗体药物的研发进展及应用
- Author:
ZHOU Jian⁃hua
;
YUE Xin
;
PAN Yong⁃bing
- Publication Type:Journal Article
- Keywords:
Respiratory viral infectious diseases；Respiratory syncytial virus（RSV）；Influenza virus（IFV）；Coronavirus （CoV）；Monoclonal antibod
- From:
Chinese Journal of Biologicals
2023;36(1):89-97
- CountryChina
- Language:Chinese
-
Abstract:
Abstract：In recent years，the outbreak and prevalence of respiratory infectious diseases in the world seriously endanger
human health，among which the respiratory infectious diseases caused by viral infection account for a large proportion. The
use of vaccines and common antiviral drugs is an effective way to fight viral infection，but there are also problems such as lag
and drug resistance. Monoclonal antibodies against respiratory viral infections provide a new strategy for clinical
treatment. This paper reviews the development of monoclonal antibody against respiratory virus and its application in
respiratory viral infectious diseases.
Keywords：Respiratory viral infectious diseases；Respiratory syncytial virus（RSV）；Influenza virus（IFV）；Coronavirus
（CoV）；Monoclonal antibody
- Full text:抗呼吸道病毒单克隆抗体药物的研发进展及应用.pdf
